Mechanism of action |
Acepromazine acts as an antagonist (blocking agent) on different
postsysnaptic receptors -on dopaminergic-receptors (subtypes D1, D2, D3
and D4 - different antipsychotic properties on productive and
unproductive symptoms), on serotonergic-receptors (5-HT1 and 5-HT2, with
anxiolytic, antidepressive and antiaggressive properties as well as an
attenuation of extrapypramidal side-effects, but also leading to weight
gain, fall in blood pressure, sedation and ejaculation difficulties), on
histaminergic-receptors (H1-receptors, sedation, antiemesis, vertigo,
fall in blood pressure and weight gain), alpha1/alpha2-receptors
(antisympathomimetic properties, lowering of blood pressure, reflex
tachycardia, vertigo, sedation, hypersalivation and incontinence as well
as sexual dysfunction, but may also attenuate pseudoparkinsonism -
controversial) and finally on muscarinic (cholinergic) M1/M2-receptors
(causing anticholinergic symptoms like dry mouth, blurred vision,
obstipation, difficulty/inability to urinate, sinus tachycardia,
ECG-changes and loss of memory, but the anticholinergic action may
attenuate extrapyramidal side-effects). |
Toxicity |
Agitation, coma, convulsions, difficulty breathing, difficulty
swallowing, dry mouth, extreme sleepiness, fever, intestinal blockage,
irregular heart rate, low blood pressure, restlessness |
Comments
Post a Comment